Page 4 - Liberia Ministry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ebola vaccine regimens safe, immunogenic in adults and children

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results.

Sierra leonePartnership for research on ebola virusLondon school of hygiene tropical medicineLiberia ministry of healthFrench national institute of healthNational institute of allergyUs national institutes of healthMerck sharp dohme corpUniversity clinical research centerVaccine developmentPartnership for research on ebola vaccinationNew england journalEbola vaccinationFrench national instituteMedical researchLondon school

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults

According to a study published in The New England Journal of Medicine, the Johnson & Johnson's and Merck's vaccines for Ebola created lasting antibodies.

Brian greenwoodLondon school of hygiene tropical medicineLiberia ministry of healthNational institutes of healthWorld health organizationMerck coUs national institute of allergyUniversity clinical research centerVaccine developmentWestern africaBavarian nordicInfectious diseasesNational institutesLondon schoolLiberia ministryNew england journal

Ebola vaccine regimens safe, immunogenic in adults and children

Ebola vaccine regimens safe, immunogenic in adults and children
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Sierra leonePartnership for research on ebola virusDivision of clinical researchLondon school of hygiene tropical medicineLiberia ministry of healthFrench national institute of healthNational institute of allergyUs national institutes of healthMerck sharp dohme corpUniversity clinical research centerVaccine developmentPartnership for research on ebola vaccinationNew england journalEbola vaccinationFrench national instituteMedical research

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

By Nandhini Srinivasan and Leroy Leo (Reuters) - Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and a.

Brian greenwoodLeroy leoNandhini srinivasanLondon school of hygiene tropical medicineLiberia ministry of healthNational institutes of healthWorld health organizationMerck coUs national institute of allergyUniversity clinical research centerVaccine developmentWestern africaBavarian nordicInfectious diseasesNational institutesLondon school

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

United statesBrian greenwoodJohnson zabdenoLondon school of hygiene tropical medicineLiberia ministry of healthNational institutes of healthWorld health organizationMerck coUniversity clinical research centerUnited states national institute of allergyVaccine developmentNew england journalBavarian nordicUnited states national instituteInfectious diseasesNational institutes